Krista A. Payne
As the Global Head, Peri- and Post-Approval Studies (PPAS) for Evidera, a PPD business, Krista is responsible for providing strategic direction and scientific and operational excellence for the company’s data analytics, non-interventional, and interventional studies practice areas.
Krista has a longstanding history with Evidera and has worked with life science companies across all product phases to develop value demonstration strategies and integrated real-world solutions to meet multiple stakeholder needs and maximize market potential. She has a proven ability to think strategically and lead collaboratively and has a reputation for building high-performing, multi-disciplinary teams. Krista offers 20 years of applied scientific and management experience across a diversity of prospective and retrospective methodologies including disease and product registries, HEOR burden of illness studies and surveys, patient wellness program evaluations, time and motion studies, and chart reviews. She has served as a principal investigator for numerous multinational observational studies, registries, and peri- and post-approval programs across a diversity of therapeutic areas.
Over the course of her career, Krista has successfully built and led research units responsible for real-world data strategy, as well as the design and conduct of real-world evidence, non-interventional studies to demonstrate treatment effectiveness, burden of illness, unmet need, resource utilization, medication adherence, and treatment satisfaction. Krista routinely serves as a chairperson and presenter at various scientific meetings and industry forums, and she has published more than a dozen scientific manuscripts in peer-reviewed journals.
Krista received her bachelor’s degree in psychology from Queen’s University in Kingston, Ontario, Canada, and her master’s degree in educational psychology from McGill University in Montreal, Quebec, Canada.